Miranda, A.C.C.; dos Santos, S.N.; Fuscaldi, L.L.; Balieiro, L.M.; Bellini, M.H.; Guimarães, M.I.C.C.; de Araújo, E.B.
Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties. Pharmaceutics 2021, 13, 971.
https://doi.org/10.3390/pharmaceutics13070971
AMA Style
Miranda ACC, dos Santos SN, Fuscaldi LL, Balieiro LM, Bellini MH, Guimarães MICC, de Araújo EB.
Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties. Pharmaceutics. 2021; 13(7):971.
https://doi.org/10.3390/pharmaceutics13070971
Chicago/Turabian Style
Miranda, Ana Cláudia Camargo, Sofia Nascimento dos Santos, Leonardo Lima Fuscaldi, Luiza Mascarenhas Balieiro, Maria Helena Bellini, Maria Inês Calil Cury Guimarães, and Elaine Bortoleti de Araújo.
2021. "Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties" Pharmaceutics 13, no. 7: 971.
https://doi.org/10.3390/pharmaceutics13070971
APA Style
Miranda, A. C. C., dos Santos, S. N., Fuscaldi, L. L., Balieiro, L. M., Bellini, M. H., Guimarães, M. I. C. C., & de Araújo, E. B.
(2021). Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties. Pharmaceutics, 13(7), 971.
https://doi.org/10.3390/pharmaceutics13070971
